Skip to main content
. 2020 Aug 13;16:741–747. doi: 10.2147/TCRM.S246328

Table 4.

The Top 10 Adverse Drug Events Associated with Infliximab

PT Infliximab
n ROR 95% CI
Pneumonia 1254 5.04 4.75–5.34*
Pneumocystis jirovecii pneumonia 888 14.5 13.5–15.5*
Interstitial lung disease 799 1.78 1.66–1.92*
Infusion related reaction 679 58.6 53.4–64.3*
Herpes zoster 412 6.82 6.17–7.55*
Sepsis 409 3.79 3.43–4.19*
Pulmonary tuberculosis 384 32.2 28.7–36.1*
Pyrexia 381 1.62 1.47–1.8*
Pneumonia bacterial 323 10.5 9.37–11.8*
Lymphoma 306 18.4 16.3–20.8*

Note: *Signal detected.

Abbreviations: CI, confidence interval; PT, preferred terms; ROR, reporting odds ratio.